Robot-assisted surgery for advanced pelvic cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of laparoscopic robot-assisted pelvic exenteration in patients with locally advanced pelvic cancers, including rectal and sigmoid cancers, as well as recurrent cervical and endometrial cancers. The study aims to achieve R0 resection, which is defined as having more than 1 mm of healthy tissue surrounding the tumor, thereby improving patient outcomes. It will assess various endpoints such as conversion rates to open surgery, postoperative complications, hospital stay duration, and quality of life over a follow-up period of five years. The trial is open-label and observational, focusing on the surgical approach and its implications for patient survival and recovery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients (\>18 years)
* locally advanced pelvic cancer that require pelvic exenteration
* eligible for robot- assisted minimally invasive surgery by the respective multidisciplinary teams, may be included in the study.

Exclusion Criteria:

* Any reason why the patient in the investigator's opinion is not suited for inclusion.

Where it's running

• Oslo University Hospital The Radium Hospital
  Oslo, Norway Recruiting

Study contacts

• Study coordinator: Ebbe B Thorgersen, MD PhD
• Email: ebbtho@rr-research.no
• Phone: +4748144121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Proton Re-irradiation for Recurrent or Second Primary Head and Neck Cancer

  This study tests proton radiotherapy to see if it can control head and neck cancer that has come back or appeared again in the same area, while trying to limit side effects.

  Recruiting Oslo University Hospital · Bergen and 3 other locations · NCT07922967

• Predicting high-risk arrhythmic events in people with arrhythmic mitral valve prolapse

  This study tests a risk model to see which patients with arrhythmic mitral valve prolapse might need an ICD.

  Recruiting Oslo University Hospital · Oslo · NCT07830888

• Digital long-term follow-up for heart disease survivors using HeartCheck

  A smartphone-based program called HeartCheck is tested to help adults who survived a recent heart attack or PCI stay on top of risk factors and medications over time.

  Recruiting at 2 sites Oslo University Hospital · Arendal and 1 other locations · NCT07720349

• Biomarker tests in adults with lupus to see how kidney disease changes over time

  Researchers will follow adults with lupus to see if blood and urine biomarkers can predict kidney involvement, flares, and treatment responses during routine care.

  Recruiting Oslo University Hospital · Oslo, Oslo · NCT07666711

• Liver health check plus brief alcohol support for hospitalized adults

  In hospitalized adults who drink harmfully, doctors will test liver stiffness and offer personalized brief alcohol advice to see if it helps reduce drinking compared with usual care.

  Recruiting Oslo University Hospital · Bergen and 7 other locations · NCT07637539

• Comparing CT and MRI with VI-RADS for Bladder Cancer Staging

  This study tests how well CT and MRI with VI-RADS can correctly stage bladder cancer before surgery in adults.

  Recruiting Oslo University Hospital · Oslo · NCT07602010

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.